ArticleNano-micro letters2026
Dopant-Free Ultra-Thin Spiro-OMeTAD Enables Near 30%-Efficient n-i-p Perovskite/Silicon Tandem Solar Cells.
Article in Nano-micro letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A major challenge for n-i-p structured perovskite/silicon tandem solar cells (TSCs) is the use of 2,2',7,7'-tetrakis[N,N-di(4-methoxyphenyl)amino]-9,9'-spirobifluorene (spiro-OMeTAD), a commonly used hole transport layer, which induces significant optical losses and consequently reduces device current. Herein, we propose an ultra-thin (10 nm) vacuum thermal evaporation (VTE)-deposited spiro-OMeTAD, coupled with a 2D/3D perovskite heterojunction, to simultaneously enhance the optical and electrical properties of n-i-p perovskite/silicon TSCs. Our results demonstrate that the 10-nm-thick spiro-OMeTAD layer significantly improves optical performance, achieving a 92.2% reduction in parasitic absorption and an 18.4% decrease in reflection losses. Additionally, the incorporation of the 2D/3D perovskite heterojunction facilitates improved molecular arrangement and enhanced surface uniformity of the ultrathin spiro-OMeTAD, leading to higher tolerance to interface defects and more efficient hole extraction. Consequently, n-i-p perovskite/silicon TSCs featuring ultrathin spiro-OMeTAD exhibit remarkable efficiencies of 29.73% (0.135 cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.